Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Revealed: UK patients stockpile drugs in fear of no-deal Brexit

Ministers have been urged by top doctors to reveal the extent of national drug stocks, amid growing evidence patients are stockpiling medication in preparation for a no-deal Brexit. The Royal College of Physicians (RCP), which represents tens of thousands of doctors, urged the government to be more “transparent about national stockpiles, particularly for things that are already in short supply or need refrigeration, such as insulin”.

Published
9 hours ago
From
The Guardian
HIV care: Karnataka bags top spot

When it comes to providing care, support and treatment to HIV patients, Karnataka has been judged the best performer among states with a high HIV burden.

Published
16 January 2019
From
Times of India
Indonesia seeks to reassure HIV patients over drug supplies

Indonesia’s health ministry has sought to reassure HIV patients that sufficient antiretroviral (ARV) drugs will be available for their treatment after some hospitals had run out of supplies.

Published
14 January 2019
From
Reuters
BASHH, BHIVA, HIVPA and NHIVNA statement on management of antiretroviral supplies in preparation for a no-deal Brexit Scenario

Clinicians do not need to issue longer, or earlier than usual, prescriptions and patients should be reassured that there is no need for concern about the supply of their medication and therefore no need to stockpile.

Published
11 January 2019
From
British HIV Association
UK-CAB statement on Brexit, HIV and access to medicines

On 19 December 2018, the UK-CAB, an HIV treatment advocacy organisation, published recommendations to mimimise the risk for HIV positive people having an interruption in supply of medicines, due to uncertainty over plans for Brexit.

Published
20 December 2018
From
UK-CAB
Benefits of dolutegravir treatment for all substantially outweigh the risks

Providing an antiretroviral regimen of dolutegravir, tenofovir and lamivudine to all adults living with HIV in sub-Saharan Africa, regardless of viral suppression or plans to have children,

Published
17 December 2018
By
Keith Alcorn
With no antiretrovirals, Venezuela HIV patients rely on leaf remedy

As Venezuela’s hyperinflation and chronic medicine shortages leave HIV patients with little hope of obtaining antiretroviral drugs, many are now relying on the leaves of a tropical tree known as the guasimo.

Published
13 December 2018
From
Reuters
Stigma, access and testing: why HIV is still rising in Europe

The latest annual surveillance report by the European Centre for Disease Prevention and Control (ECDC) shows that Europe maintains its distinction as the World Health

Published
11 December 2018
By
Gus Cairns
Bringing Down the House on Intellectual Property and Access

As the Trump administration makes noise about the high price of pharmaceuticals while doubling down on its commitment to “protect the engine of American ingenuity,” this issue of TAGline dives deep into the rhetoric and realities of intellectual property (IP) protections and the current wave of political shenanigans on critical drugs, surfacing the fundamental lies and vested interests that deny medication to those in need in the United States and around the world.

Published
10 December 2018
From
Treatment Action Group
Asylum seekers in Britain unable to access healthcare

Cost and fears about how they will be treated, or consequences for their immigration status, are preventing people seeking or refused asylum from using health services, a new report from the Equality and Human Rights Commission has found, prompting a call for greater separation of the immigration and healthcare systems.

Published
30 November 2018
From
Equality and Human Rights Commission
← First12345...139Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.